China Medipharm Insights - July 2001


Regular Price: USD 1,000.00

Special Price USD 700.00

30% OFF

* Required Fields

Regular Price: USD 1,000.00

Special Price USD 700.00


Be the first to review this product

Table of Contents

China Medipharm Insights - July 2001, China Medipharm Insights - July 2001Drug ConsumptionAnalysis of Drug Consumption in Shanghai Hospitals in the First Quarter of 2001 Hospital Consumption of Gastrointestinal Drugs in Southwest China During 1999-2000The Ten Best-selling Drugs by Generic Names and Brand NamesProduct NewsPyrantel Pamoate Tartrate Granted FDA CertificationViagra Receives Chinese Patent ProtectionAntidepressant Remeron Marketed in China Ipristeride Concludes Phase IV Clinical TrialsPlavix To Be Launched by Sanofi-Synthelabo MinshengAnti-emetic Bangyue DevelopedAnti-tumor Weimaining Approved Phase II Clinical Trials by FDAGlimpiride Launched by Beijing Capital Enterprise GroupMTC-adriamycin Approved Phase II Clinical Trials in ChinaTPA Applied for State Class I New DrugDiammonium Glycyrrhizinate Glucose Injections Launched by Lianyungang Chia TaiKaximeng Injections Put into ProductionAnti-tuberculosis Weika DevelopedMarket analysisMarket Analysis of Anti-obesity ProductsMarket Analysis of Amoxicillin/ Clavulanate Potassium in Beijing and JinanMajor Suppliers of Amoxicillin/Clavulanate PotassiumDrug ConsumptionConsumption Analysis in Hunan Hospitals during 1996-2000Company ProfilesHayao Group Opens A Drug SupermarketXinhua Lukang Sets up Drug Retailing Chains Co. Ltd.Taitai Pharma Goes PublicTechnological Upgrading Adds New Wings to Hayao GroupLukang’s Streptomycin Wins An International BidTopsun Expands through Mergers & AcquisitionsDong’E Ejiao Makes Investment in Biochip Largest Retail Drug Store Opened in ShenzhenHebei Introduces Biochip Technology999 Changzheng Prospers on Restructuring 999 Group Sets up Joint Venture in JapanNew Success Pharma Put into ProductionDisease ControlChina Vows to Control TuberculosisHepatitis B Vaccination Brings Hope for Liver Cancer ControlNew Statistics on Cancer Released in Shanghai Sixteen Percent of Chinese People above 40 Affected with OsteoporosisEpilepsy is Prevalent in Seven Percent of Chinese PopulationOrgan Transplantation in ChinaDrug ProcurementLargest Unified Drug Procurement Through Bidding Closes in BeijingMOH Affiliated Hospitals Procure Drugs Through BiddingDistrict Level Hospitals in Beijing Conduct Online Unified Drug Procurement Through BiddingAnhui to Expand Unified Drug Procurement Through BiddingUnified Drug Procurements via Bidding Lead to Drug Price Cuts in XinjiangHubei Adopts Unified Drug Procurement Through BiddingUnified Drug Procurements Benefit From E-commerceUnified Drug Procurements Save US$12 Million Drug Expenses in FujianDevice ProcurementFoshan to Conduct Online Unified Drug Procurement Through BiddingNanjing Issues Regulations on Drug Pricing Through Unified Drug Procurement by BiddingMilitary Hospitals Conduct Unified Drug ProcurementThrough Bidding in KunmingNews in BriefSecond OTC Drug List ReleasedSeventy Two Percent of New Drug Applications Submitted by a Single ApplicantChina is in Urgent Need of Certified PharmacistsState New Drug Development Engineering Technology Center EstablishedBeijing Sets Ceiling Prices for 42 AntibioticsShanghai Makes Price Cut on DrugsSenior Citizens Spend Two Thirds of Insurance Premium in ShanghaiShanghai Gears up to Put Certified Pharmacists in Retail Drug StoresMedical Expenses See Drop in AnhuiNanjing to Inspect Drug PricesAnti-tumor Drug Screening Model Based on Gene Chips Developed in Shanghai

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.